Cargando…
Palmitoyl transferases act as novel drug targets for pancreatic cancer
BACKGROUND: Pancreatic adenocarcinoma (PAAD) is one of the most leading causes of cancer-related death across the world with the limited efficiency and response rate of immunotherapy. Protein S-palmitoylation, a powerful post-translational lipid modification, is well-known to regulate the stability...
Autores principales: | Lin, Zhiqing, Lv, Ziru, Liu, Xin, Huang, Keke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084701/ https://www.ncbi.nlm.nih.gov/pubmed/37038141 http://dx.doi.org/10.1186/s12967-023-04098-3 |
Ejemplares similares
-
Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression
por: Tang, Feng, et al.
Publicado: (2022) -
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer
por: Tan, Zheqiong, et al.
Publicado: (2021) -
Palmitoylation of the Cysteine Residue in the DHHC Motif of a Palmitoyl Transferase Mediates Ca(2+) Homeostasis in Aspergillus
por: Zhang, Yuanwei, et al.
Publicado: (2016) -
Plasmodium palmitoylation machinery engineered in E. coli for high‐throughput screening of palmitoyl acyl‐transferase inhibitors
por: Yadav, Preeti, et al.
Publicado: (2019) -
Correction: Carnitine palmitoyl transferase 1 A is a novel diagnostic and predictive biomarker for breast cancer
por: Tan, Zheqiong, et al.
Publicado: (2023)